{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:14:29Z","timestamp":1768439669285,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol. Sin."],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12250-020-00234-1","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T05:02:41Z","timestamp":1590469361000},"page":"354-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: \u201cAdenovirus Vaccine Within an Adenovirus Vector\u201d"],"prefix":"10.1016","volume":"36","author":[{"given":"Yuqian","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuping","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxian","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendong","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2770-111X","authenticated-orcid":false,"given":"Qiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"key":"234_CR1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jmv.23969","volume":"87","author":"MA Alkhalaf","year":"2015","unstructured":"Alkhalaf MA, Guiver M, Cooper RJ (2015) Genome stability of adenovirus types 3 and 7 during a simultaneous outbreak in Greater Manchester, UK. J Med Virol 87:117\u2013124","journal-title":"J Med Virol"},{"key":"234_CR2","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/infdis\/jiu217","volume":"210","author":"LR Baden","year":"2014","unstructured":"Baden LR, Walsh SR, Seaman MS, Johnson JA, Tucker RP, Kleinjan JA, Gothing JA, Engelson BA, Carey BR, Oza A, Bajimaya S, Peter L, Bleckwehl C, Abbink P, Pau MG, Weijtens M, Kunchai M, Swann EM, Wolff M, Dolin R, Barouch DH (2014) First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002). J Infect Dis 210:1052\u20131061","journal-title":"J Infect Dis"},{"key":"234_CR3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jmv.21045","volume":"80","author":"SY Chang","year":"2008","unstructured":"Chang SY, Lee CN, Lin PH, Huang HH, Chang LY, Ko W, Chang SF, Lee PI, Huang LM, Kao CL (2008) A community-derived outbreak of adenovirus type 3 in children in Taiwan between 2004 and 2005. J Med Virol 80:102\u2013112","journal-title":"J Med Virol"},{"key":"234_CR4","doi-asserted-by":"crossref","first-page":"e0155412","DOI":"10.1371\/journal.pone.0155412","volume":"11","author":"Y Chen","year":"2016","unstructured":"Chen Y, Liu F, Wang C, Zhao M, Deng L, Zhong J, Zhang Y, Ye J, Jing S, Cheng Z, Guan Y, Ma Y, Sun Y, Zhu B, Zhang Q (2016) Molecular identification and epidemiological features of human adenoviruses associated with acute respiratory infections in hospitalized children in Southern China, 2012\u20132013. PLoS ONE 11:e0155412","journal-title":"PLoS ONE"},{"key":"234_CR5","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3389\/fmicb.2018.01180","volume":"9","author":"Z Cheng","year":"2018","unstructured":"Cheng Z, Yan Y, Jing S, Li WG, Chen WW, Zhang J, Li M, Zhao S, Cao N, Ou J, Zhao S, Wu X, Cao B, Zhang Q (2018) Comparative genomic analysis of re-emergent human adenovirus type 55 pathogens associated with adult severe community-acquired pneumonia reveals conserved genomes and capsid proteins. Front Microbiol 9:1180","journal-title":"Front Microbiol"},{"key":"234_CR6","first-page":"566","volume":"221","author":"KK Coleman","year":"2019","unstructured":"Coleman KK, Wong CC, Jayakumar J, Nguyen TT, Wong AWL, Yadana S, Thoon KC, Chan KP, Low JG, Kalimuddin S, Dehghan S, Kang J, Shamsaddini A, Seto D, Su YCF, Gray GC (2019) Adenoviral infections in Singapore: should new antiviral therapies and vaccines be adopted? J Infect Dis. 221:566\u2013577","journal-title":"J Infect Dis"},{"key":"234_CR7","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/jvi.70.3.1836-1844.1996","volume":"70","author":"L Crawford-Miksza","year":"1996","unstructured":"Crawford-Miksza L, Schnurr DP (1996) Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues. J Virol 70:1836\u20131844","journal-title":"J Virol"},{"key":"234_CR8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1099\/jgv.0.000978","volume":"99","author":"MR Duffy","year":"2017","unstructured":"Duffy MR, Alonso-Padilla J, John L, Chandra N, Khan S, Ballmann MZ, Lipiec A, Heemskerk E, Custers J, Arnberg N, Havenga M, Baker AH, Lemckert A (2017) Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56. J Gen Virol. 99:135\u2013147","journal-title":"J Gen Virol"},{"key":"234_CR9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/9780470741405.ch19","volume-title":"Principles and practice of clinical virology","author":"M Echavarr\u00eda","year":"2009","unstructured":"Echavarr\u00eda M (2009) Adenoviruses. In: Zuckerman AJ, Banatvala JE, Schoub BD, Griffiths PD, Mortime P (eds) Principles and practice of clinical virology, 6th edn. Wiley, Chichester, pp 463\u2013488","edition":"6"},{"key":"234_CR10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.virol.2018.03.002","volume":"518","author":"Y Feng","year":"2018","unstructured":"Feng Y, Sun X, Ye X, Feng Y, Wang J, Zheng X, Liu X, Yi C, Hao M, Wang Q, Li F, Xu W, Li L, Li C, Zhou R, Chen L, Feng L (2018) Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity. Virology 518:272\u2013283","journal-title":"Virology"},{"key":"234_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7883\/yoken.JJID.2008.143","volume":"61","author":"T Fujimoto","year":"2008","unstructured":"Fujimoto T, Hamamoto I, Taniguchi K, Chikahira M, Okabe N (2008) Molecular epidemiology of adenovirus type 3 detected from 1994 to 2006 in Hyogo Prefecture, Japan. Jpn J Infect Dis 61:143\u2013145","journal-title":"Jpn J Infect Dis"},{"key":"234_CR12","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.72.3.2388-2397.1998","volume":"72","author":"H Gahery-Segard","year":"1998","unstructured":"Gahery-Segard H, Farace F, Godfrin D, Gaston J, Lengagne R, Tursz T, Boulanger P, Guillet JG (1998) Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J Virol 72:2388\u20132397","journal-title":"J Virol"},{"key":"234_CR13","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1002\/jgm.3015","volume":"20","author":"SL Ginn","year":"2018","unstructured":"Ginn SL, Amaya AK, Alexander IE, Edelstein M, Abedi MR (2018) Gene therapy clinical trials worldwide to 2017: an update. J Gene Med 20:e3015","journal-title":"J Gene Med"},{"key":"234_CR14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1743-422X-11-112","volume":"11","author":"L Gu","year":"2014","unstructured":"Gu L, Krendelchtchikova V, Krendelchtchikov A, Oster RA, Fujihashi K, Matthews QL (2014) A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the \u201cAntigen Capsid-Incorporation\u201d strategy. Virol J 11:112","journal-title":"Virol J"},{"key":"234_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12250-013-3308-7","volume":"28","author":"G Han","year":"2013","unstructured":"Han G, Niu H, Zhao S, Zhu B, Wang C, Liu Y, Zhang M, Yang S, Liu F, Wan C, Zhang Q (2013) Identification and typing of respiratory adenoviruses in Guangzhou, Southern China using a rapid and simple method. Virol Sin 28:103\u2013108","journal-title":"Virol Sin"},{"key":"234_CR16","first-page":"9","volume":"25","author":"D Harley","year":"2001","unstructured":"Harley D, Harrower B, Lyon M, Dick A (2001) A primary school outbreak of pharyngoconjunctival fever caused by adenovirus type 3. Commun Dis Intell 25:9\u201312","journal-title":"Commun Dis Intell"},{"key":"234_CR17","doi-asserted-by":"crossref","first-page":"13207","DOI":"10.1128\/JVI.78.23.13207-13215.2004","volume":"78","author":"L Holterman","year":"2004","unstructured":"Holterman L, Vogels R, van der Vlugt R, Sieuwerts M, Grimbergen J, Kaspers J, Geelen E, van der Helm E, Lemckert A, Gillissen G, Verhaagh S, Custers J, Zuijdgeest D, Berkhout B, Bakker M, Quax P, Goudsmit J, Havenga M (2004) Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5. J Virol 78:13207\u201313215","journal-title":"J Virol"},{"key":"234_CR18","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3201\/eid2509.181937","volume":"25","author":"S Jing","year":"2019","unstructured":"Jing S, Zhang J, Cao M, Liu M, Yan Y, Zhao S, Cao N, Ou J, Ma K, Cai X, Wu J, Mei Y-F, Zhang Q (2019) Household transmission of human adenovirus type 55 in case of fatal acute respiratory disease. Emerg Infect Dis 25:1756\u20131758","journal-title":"Emerg Infect Dis"},{"key":"234_CR19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jcv.2009.09.023","volume":"46","author":"MG Lebeck","year":"2009","unstructured":"Lebeck MG, McCarthy TA, Capuano AW, Schnurr DP, Landry ML, Setterquist SF, Heil GL, Kilic S, Gray GC (2009) Emergent US adenovirus 3 strains associated with an epidemic and serious disease. J Clin Virol 46:331\u2013336","journal-title":"J Clin Virol"},{"key":"234_CR20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/jmv.21701","volume":"82","author":"J Lee","year":"2010","unstructured":"Lee J, Choi EH, Lee HJ (2010) Comprehensive serotyping and epidemiology of human adenovirus isolated from the respiratory tract of Korean children over 17 consecutive years (1991\u20132007). J Med Virol 82:624\u2013631","journal-title":"J Med Virol"},{"key":"234_CR21","doi-asserted-by":"crossref","first-page":"e0205795","DOI":"10.1371\/journal.pone.0205795","volume":"13","author":"L Li","year":"2018","unstructured":"Li L, Woo YY, de Bruyne JA, Nathan AM, Kee SY, Chan YF, Chiam CW, Eg KP, Thavagnanam S, Sam IC (2018) Epidemiology, clinical presentation and respiratory sequelae of adenovirus pneumonia in children in Kuala Lumpur, Malaysia. PLoS One 13:e0205795","journal-title":"PLoS One"},{"key":"234_CR22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jmii.2018.07.005","volume":"52","author":"GL Lin","year":"2019","unstructured":"Lin GL, Lu CY, Chen JM, Lee PI, Ho SY, Weng KC, Huang LM, Chang LY (2019) Molecular epidemiology and clinical features of adenovirus infection in Taiwanese children, 2014. J Microbiol Immunol Infect 52:215\u2013224","journal-title":"J Microbiol Immunol Infect"},{"key":"234_CR23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","volume":"27","author":"T Lion","year":"2014","unstructured":"Lion T (2014) Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev 27:441\u2013462","journal-title":"Clin Microbiol Rev"},{"key":"234_CR24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/gt.2008.72","volume":"15","author":"TC Liu","year":"2008","unstructured":"Liu TC, Kirn D (2008) Gene therapy progress and prospects cancer: oncolytic viruses. Gene Ther 15:877\u2013884","journal-title":"Gene Ther"},{"key":"234_CR25","first-page":"9304830","volume":"2017","author":"L Lu","year":"2017","unstructured":"Lu L, Zhong H, Su L, Cao L, Xu M, Dong N, Xu J (2017) Detection and molecular characterization of human adenovirus infections among hospitalized children with acute diarrhea in Shanghai, China, 2006\u20132011. Can J Infect Dis Med Microbiol 2017:9304830","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"234_CR26","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","volume":"315","author":"ID Milligan","year":"2016","unstructured":"Milligan ID, Gibani MM, Sewell R, Clutterbuck EA, Campbell D, Plested E, Nuthall E, Voysey M, Silva-Reyes L, McElrath MJ, De Rosa SC, Frahm N, Cohen KW, Shukarev G, Orzabal N, van Duijnhoven W, Truyers C, Bachmayer N, Splinter D, Samy N, Pau MG, Schuitemaker H, Luhn K, Callendret B, Van Hoof J, Douoguih M, Ewer K, Angus B, Pollard AJ, Snape MD (2016) Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia ankara-vectored Ebola vaccines: a randomized clinical trial. JAMA 315:1610\u20131623","journal-title":"JAMA"},{"key":"234_CR27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/v10100568","volume":"10","author":"H Pan","year":"2018","unstructured":"Pan H, Yan Y, Zhang J, Zhao S, Feng L, Ou J, Cao N, Li M, Zhao W, Wan C, Ismail AM, Rajaiya J, Chodosh J, Zhang Q (2018) Rapid construction of a replication-competent infectious clone of human adenovirus type 14 by gibson assembly. Viruses 10:568","journal-title":"Viruses"},{"key":"234_CR28","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1016\/j.vaccine.2008.08.022","volume":"26","author":"L Pena","year":"2008","unstructured":"Pena L, Moraes MP, Koster M, Burrage T, Pacheco JM, Segundo FD, Grubman MJ (2008) Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine. Vaccine 26:5689\u20135699","journal-title":"Vaccine"},{"key":"234_CR29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S0950268815000916","volume":"144","author":"SA Pereira","year":"2016","unstructured":"Pereira SA, Florencio CM, Marinheiro JC, Harsi CM, Moura FE (2016) Adenoviruses and acute respiratory infections in children living in an equatorial area of Brazil. Epidemiol Infect 144:355\u2013362","journal-title":"Epidemiol Infect"},{"key":"234_CR30","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.vaccine.2013.01.023","volume":"31","author":"W Peters","year":"2013","unstructured":"Peters W, Brandl JR, Lindbloom JD, Martinez CJ, Scallan CD, Trager GR, Tingley DW, Kabongo ML, Tucker SN (2013) Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-gamma T cell responses in humans. Vaccine 31:1752\u20131758","journal-title":"Vaccine"},{"key":"234_CR31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0042-6822(61)90357-9","volume":"15","author":"L Philipson","year":"1961","unstructured":"Philipson L (1961) Adenovirus assay by the fluorescent cell-counting procedure. Virology 15:263\u2013268","journal-title":"Virology"},{"key":"234_CR32","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/JVI.02023-06","volume":"81","author":"SL Pichla-Gollon","year":"2007","unstructured":"Pichla-Gollon SL, Drinker M, Zhou X, Xue F, Rux JJ, Gao GP, Wilson JM, Ertl HC, Burnett RM, Bergelson JM (2007) Structure-based identification of a major neutralizing site in an adenovirus hexon. J Virol 81:1680\u20131689","journal-title":"J Virol"},{"key":"234_CR33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/cid\/ciu507","volume":"59","author":"JM Radin","year":"2014","unstructured":"Radin JM, Hawksworth AW, Blair PJ, Faix DJ, Raman R, Russell KL, Gray GC (2014) Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines. Clin Infect Dis 59:962\u2013968","journal-title":"Clin Infect Dis"},{"key":"234_CR34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1874467210801010013","volume":"1","author":"JK R\u00e4ty","year":"2008","unstructured":"R\u00e4ty JK, Pikkarainen JT, Wirth T, Yl\u00e4-Herttuala S (2008) Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications. Curr Mol Pharmacol 1:13\u201323","journal-title":"Curr Mol Pharmacol"},{"key":"234_CR35","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.vaccine.2005.12.062","volume":"24","author":"KL Russell","year":"2006","unstructured":"Russell KL, Hawksworth AW, Ryan MA, Strickler J, Irvine M, Hansen CJ, Gray GC, Gaydos JC (2006) Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999\u20132004. Vaccine 24:2835\u20132842","journal-title":"Vaccine"},{"key":"234_CR36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/mthe.1999.0001","volume":"1","author":"JJ Rux","year":"2000","unstructured":"Rux JJ, Burnett RM (2000) Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon. Mol Ther 1:18\u201330","journal-title":"Mol Ther"},{"key":"234_CR37","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1128\/JVI.77.17.9553-9566.2003","volume":"77","author":"JJ Rux","year":"2003","unstructured":"Rux JJ, Kuser PR, Burnett RM (2003) Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods. J Virol 77:9553\u20139566","journal-title":"J Virol"},{"key":"234_CR38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/CVI.00552-12","volume":"20","author":"CD Scallan","year":"2013","unstructured":"Scallan CD, Tingley DW, Lindbloom JD, Toomey JS, Tucker SN (2013) An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models. Clin Vaccine Immunol 20:85\u201394","journal-title":"Clin Vaccine Immunol"},{"key":"234_CR39","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/655468","volume":"202","author":"RT Schooley","year":"2010","unstructured":"Schooley RT, Spritzler J, Wang H, Lederman MM, Havlir D, Kuritzkes DR, Pollard R, Battaglia C, Robertson M, Mehrotra D, Casimiro D, Cox K, Schock B (2010) AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein. J Infect Dis 202:705\u2013716","journal-title":"J Infect Dis"},{"key":"234_CR40","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1128\/JVI.00354-11","volume":"85","author":"D Seto","year":"2011","unstructured":"Seto D, Chodosh J, Brister JR, Jones MS, MotAR Community (2011) Using the whole-genome sequence to characterize and name human adenoviruses. J Virol 85:5701\u20135702","journal-title":"J Virol"},{"key":"234_CR41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/21645515.2017.1264755","volume":"13","author":"G Shukarev","year":"2017","unstructured":"Shukarev G, Callendret B, Luhn K, Douoguih M, Consortium E (2017) A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks. Hum Vaccin Immunother 13:266\u2013270","journal-title":"Hum Vaccin Immunother"},{"key":"234_CR42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.virol.2015.08.018","volume":"485","author":"G Singh","year":"2015","unstructured":"Singh G, Zhou X, Lee JY, Yousuf MA, Ramke M, Ismail AM, Lee JS, Robinson CM, Seto D, Dyer DW, Jones MS, Rajaiya J, Chodosh J (2015) Recombination of the epsilon determinant and corneal tropism: human adenovirus species D types 15, 29, 56, and 69. Virology 485:452\u2013459","journal-title":"Virology"},{"key":"234_CR43","doi-asserted-by":"crossref","first-page":"205ra134","DOI":"10.1126\/scitranslmed.3006843","volume":"5","author":"F Smaill","year":"2013","unstructured":"Smaill F, Jeyanathan M, Smieja M, Medina MF, Thanthrige-Don N, Zganiacz A, Yin C, Heriazon A, Damjanovic D, Puri L, Hamid J, Xie F, Foley R, Bramson J, Gauldie J, Xing Z (2013) A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity. Sci Transl Med 5:205ra134","journal-title":"Sci Transl Med"},{"key":"234_CR44","first-page":"135","volume":"76","author":"H Stecher","year":"2003","unstructured":"Stecher H, Carlson CA, Shayakhmetov DM, Lieber A (2003) Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats. Methods Mol Med 76:135\u2013152","journal-title":"Methods Mol Med"},{"key":"234_CR45","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1128\/JVI.79.8.5090-5104.2005","volume":"79","author":"D Stone","year":"2005","unstructured":"Stone D, Ni S, Li Z-Y, Gaggar A, DiPaolo N, Feng Q, Sandig V, Lieber A (2005) Development and assessment of human adenovirus type 11 as a gene transfer vector. J Virol 79:5090\u20135104","journal-title":"J Virol"},{"key":"234_CR46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.virusres.2015.06.002","volume":"208","author":"X Tian","year":"2015","unstructured":"Tian X, Liu M, Su X, Jiang Z, Ma Q, Liao X, Li X, Zhou Z, Li C, Zhou R (2015) Mapping the epitope of neutralizing monoclonal antibodies against human adenovirus type 3. Virus Res 208:66\u201372","journal-title":"Virus Res"},{"key":"234_CR47","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3390\/v2091844","volume":"2","author":"K Toth","year":"2010","unstructured":"Toth K, Wold WSM (2010) Increasing the efficacy of oncolytic adenovirus vectors. Viruses 2:1844\u20131866","journal-title":"Viruses"},{"key":"234_CR48","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3201\/eid1811.120629","volume":"18","author":"TP Tsou","year":"2012","unstructured":"Tsou TP, Tan BF, Chang HY, Chen WC, Huang YP, Lai CY, Chao YN, Wei SH, Hung MN, Hsu LC, Lu CY, Shao PL, Mu JJ, Chang LY, Liu MT, Huang LM (2012) Community outbreak of adenovirus, Taiwan, 2011. Emerg Infect Dis 18:1825\u20131832","journal-title":"Emerg Infect Dis"},{"key":"234_CR49","first-page":"633","volume":"160","author":"Y Wo","year":"2014","unstructured":"Wo Y, Lu Q-B, Huang D-D, Li X-K, Guo C-T, Wang H-Y, Zhang X-A, Liu W, Cao W-C (2014) Epidemical features of HAdV-3 and HAdV-7 in pediatric pneumonia in Chongqing, China. Adv Virol 160:633\u2013638","journal-title":"Adv Virol"},{"key":"234_CR50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","volume":"13","author":"WS Wold","year":"2013","unstructured":"Wold WS, Toth K (2013) Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr Gene Ther 13:421\u2013433","journal-title":"Curr Gene Ther"},{"key":"234_CR51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1743-422X-6-11","volume":"6","author":"R Yeung","year":"2009","unstructured":"Yeung R, Eshaghi A, Lombos E, Blair J, Mazzulli T, Burton L, Drews SJ (2009) Characterization of culture-positive adenovirus serotypes from respiratory specimens in Toronto, Ontario, Canada: September 2007\u2013June 2008. Virol J 6:11","journal-title":"Virol J"},{"key":"234_CR52","doi-asserted-by":"crossref","first-page":"37216","DOI":"10.1038\/srep37216","volume":"6","author":"Z Yu","year":"2016","unstructured":"Yu Z, Zeng Z, Zhang J, Pan Y, Chen M, Guo Y, Yu N, Chodosh J, Fu N, Che X, Zhang Q (2016) Fatal community-acquired pneumonia in children caused by re-emergent human adenovirus 7d associated with higher severity of illness and fatality rate. Sci Rep 6:37216","journal-title":"Sci Rep"},{"key":"234_CR53","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1099\/vir.0.81515-0","volume":"87","author":"Q Zhang","year":"2006","unstructured":"Zhang Q, Su X, Gong S, Zeng Q, Zhu B, Wu Z, Peng T, Zhang C, Zhou R (2006) Comparative genomic analysis of two strains of human adenovirus type 3 isolated from children with acute respiratory infection in southern China. J Gen Virol 87:1531\u20131541","journal-title":"J Gen Virol"},{"key":"234_CR54","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.vaccine.2008.12.039","volume":"27","author":"Q Zhang","year":"2009","unstructured":"Zhang Q, Su X, Seto D, Zheng B-J, Tian X, Sheng H, Li H, Wang Y, Zhou R (2009) Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector. Vaccine 27:1145\u20131153","journal-title":"Vaccine"},{"key":"234_CR55","first-page":"e92","volume":"6","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Jing S, Cheng Z, Yu Z, Dehghan S, Shamsaddini A, Yan Y, Li M, Seto D (2017) Comparative genomic analysis of two emergent human adenovirus type 14 respiratory pathogen isolates in China reveals similar yet divergent genomes. Emerg Microbes Infect 6:e92","journal-title":"Emerg Microbes Infect"},{"key":"234_CR56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/v11020129","volume":"11","author":"J Zhang","year":"2019","unstructured":"Zhang J, Kang J, Dehghan S, Sridhar S, Lau S, Ou J, Woo P, Zhang Q, Seto D (2019) A survey of recent adenoviral respiratory pathogens in Hong Kong reveals emergent and recombinant human adenovirus type 4 (HAdV-E4) circulating in civilian populations. Viruses 11:129","journal-title":"Viruses"},{"key":"234_CR57","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.17.995373","author":"J Zhang","year":"2020","unstructured":"Zhang J, Sridhar S, Lau SKP, Liu J, Ou J, Yan Y, Zhao S, Lan W, Guan W, Wu J, Woo PCY, Seto D, Zhang Q (2020) Molecular typing of human respiratory adenoviruses with universal PCR and sequencing primers for three major capsid genes: penton base, hexon, and fiber. BioRxiv. https:\/\/doi.org\/10.1101\/2020.03.17.995373","journal-title":"BioRxiv"},{"key":"234_CR58","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1038\/srep07365","volume":"4","author":"S Zhao","year":"2014","unstructured":"Zhao S, Wan C, Ke C, Seto J, Dehghan S, Zou L, Zhou J, Cheng Z, Jing S, Zeng Z, Zhang J, Wan X, Wu X, Zhao W, Zhu L, Seto D, Zhang Q (2014) Re-emergent human adenovirus genome type 7d caused an acute respiratory disease outbreak in Southern China after a twenty-one year absence. Sci Rep 4:7365","journal-title":"Sci Rep"},{"key":"234_CR59","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1186\/s12879-019-4385-5","volume":"19","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Lu R, Shen J, Xie Z, Liu G, Tan W (2019) Comparison of viral and epidemiological profiles of hospitalized children with severe acute respiratory infection in Beijing and Shanghai, China. BMC Infect Dis 19:729","journal-title":"BMC Infect Dis"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-020-00234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12250-020-00234-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-020-00234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T13:23:59Z","timestamp":1696166639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12250-020-00234-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1007\/s12250-020-00234-1","relation":{},"ISSN":["1674-0769","1995-820X"],"issn-type":[{"value":"1674-0769","type":"print"},{"value":"1995-820X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,26]]},"assertion":[{"value":"22 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The whole study was approved by the Southern Medical University Animal Ethics Committee. All institutional and national guidelines for the care and use of laboratory animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal and Human Rights Statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}